Generic Drug Development CDMO

Introduction: Clinical Trial Material Manufacturing for Phase I and II is a critical part of drug development because clinical studies […]

Introduction CDMO services for Lipid Nanoparticle (LNP) Formulation and Characterization offer specialized contract development, scalable microfluidic manufacturing, and orthogonal analytical

Introduction CDMO Contract Models Explained: Contract Development and Manufacturing Organization (CDMO) contract models establish the legal, operational, and financial frameworks

Introduction Contract Development and Manufacturing Organizations (CDMOs) implement ICH Q2(R2) and ICH Q14 as an integrated, lifecycle-oriented framework that brings

Introduction CDMO Quality Agreements function as legally binding quality management frameworks established under Current Good Manufacturing Practice (CGMP) regulations to

Introduction Analytical Method Transfer Between CDMO Sites is a formal and documented process used to qualify a receiving Contract Development

Introduction Phase-Appropriate CMC Development at a CDMO represents a risk-managed approach to scaling that aligns Chemistry, Manufacturing, and Controls activities

Introduction: FDA Sameness for Complex Generic Drugs is a scientific and regulatory assessment used to determine whether a proposed generic

Introduction: Technology Transfer to GMP CDMO is one of the most technically demanding steps in bringing a first-in-generic modified-release tablet

Introduction A peptide purity testing report, commonly presented as a Certificate of Analysis (CoA) or analytical datasheet, is a critical